Exco Intouch has partnered with MMG to enhance the efficacy of patient recruitment and retention services for pharmaceutical sponsors.
Exco Intouch's React SMS technology will complement MMG's services, enhancing the company's ability to find patients through advertising, pre-screening and selection.
Additionally, Exco Intouch's mobile technology will allow MMG to interact directly with subjects during a clinical study, which can improve retention for faster and more cost-effective trials.
React SMS technology from Exco Intouch will be offered by MMG in synergy with its existing enrolment services, enabling sponsors to quickly identify and pre-screen potential subjects for clinical studies.
Exco Intouch's technology complements MMG's existing patient communication and recruitment services, offering SMS-based recruitment advertising and enabling fast assessment of potential subjects' suitability via SMS.
React produces and updates patient visit schedules, meaning site personnel do not need to refer to the trial protocol each time a change is made.
Customised visit and medication reminders are automatically sent to patients via SMS, ensuring subjects comply with the trial requirements while minimising the input required from study organisers.
